Einfluss Selektiver I(f)-Blockade Auf Orthostase-Toleranz Und Sympathikusaktivitaet Bei Gesunden.

Trial Profile

Einfluss Selektiver I(f)-Blockade Auf Orthostase-Toleranz Und Sympathikusaktivitaet Bei Gesunden.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Ivabradine (Primary) ; Metoprolol (Primary) ; Reboxetine
  • Indications Tachycardia
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Nov 2011 Actual end date (Aug 2011) added as reported by European Clinical Trials Database.
    • 16 Nov 2011 Status changed from recruiting to completed as reported by European Clinical Trials Database.
    • 25 Mar 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top